Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can plasma Epstein–Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?

Nature Clinical Practice Oncology volume 2, pages 14–15 (2005)Cite this article

boxed-textLin J-C et al. (2004) Quantification of plasma Epstein–Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350: 2461–2470

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Shotelersuk K et al. (2000) Epstein–Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer. Clin Cancer Res 3: 1046–1051

    Google Scholar 

  2. Hsiao JR et al. (2002) Detection of cell free Epstein-Barr virus DNA in sera from patients with nasopharyngeal carcinoma. Cancer 94: 723–729

    Article  CAS  Google Scholar 

  3. Lo YM et al. (1999) Quantitative and temporal correlation between circulating cell-free Epstein–Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 59: 5452–5455

    CAS  PubMed  Google Scholar 

  4. Chan AT et al. (2002) Plasma Epstein–Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94: 1614–1619

    Article  CAS  Google Scholar 

  5. Wei WI et al. (2004) Quantitative analysis of plasma cell-free Epstein–Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study. Head Neck 10: 878

    Article  Google Scholar 

  6. Fan H et al. (2004) Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein–Barr virus. Int J Cancer 112: 1036–1041

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by David Bruce, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Tumour Virology at the Department of Virology, Imperial College London,

    Paul J Farrell

Authors
  1. Paul J Farrell
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farrell, P. Can plasma Epstein–Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?. Nat Rev Clin Oncol 2, 14–15 (2005). https://doi.org/10.1038/ncponc0051

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0051

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing